Expanding footprint InClin operates in the San Francisco Bay Area and Sydney with an international reach, signaling growth potential in ANZ and US markets for new CRO partnerships, sponsor onboarding, and cross-border clinical programs.

Experienced team With 51-200 employees and an average of 20+ years in clinical research, InClin offers high-touch, experienced program leadership and continuity through trials, presenting a compelling value proposition to sponsors seeking reliable, expert execution and reduced restart risk.

Full service conductor As a single-source CRO delivering Phase 1 through Phase 4, including regulatory, data, safety, and QA, InClin can upsell expanded services to existing sponsors and win new programs that require integrated end-to-end trial management.

Quality and compliance Rigorous QA framework aligned with FDA and EMA standards, proactive communication, and on-time, on-budget delivery position InClin as a risk-averse partner ideal for sponsors with stringent regulatory and timeline requirements.

Sponsor partnerships Past collaborations and webinars with major sponsors, active emphasis on sponsor relationships, and a track record of numerous NDAs, BLAs, and pivotal trials indicate strong potential for expanded strategic partnerships and long-term renewals.